Science & evidence

Research grounded in
clinical practice.

We draw on published studies, technical documentation and clinical experience in andrology. Fertilum also contributes to ongoing Nordic research in male fertility.

135
Clinical semen samples · 2019 study [1]
31
Semen samples · 2021 study [2]
101
Aliquots analysed · 2021 study [2]
≥ 0.92
Correlation · 2021 study [2]
Scientific foundations

Three validation areas.

≥ 0.92 Correlation

X1 Pro vs. manual WHO 5 analysis

In a published comparative study, concentration and both total and progressive motility showed strong correlation between LensHooke X1 Pro, IVOS CASA and manual semen analysis performed according to the fifth edition of the WHO manual. [2]

ρ = 0.9323 Agreement with manual interpretation

R10/X12 Pro and DNA fragmentation

A study of 620 semen samples showed strong agreement between LensHooke X12 Pro and manual interpretation of R10 results. The automated analysis also had lower variation than manual assessment. [3]

≈ 5 min sORP measurement result

MiOXSYS and oxidative stress

MiOXSYS measures static oxidation-reduction potential directly in seminal plasma and provides results in approximately five minutes. [4]

Clinical publications

Verified validation.

Coming 2025
Nordic multicentre validation
Ongoing study at Nordic university hospitals. Publishing Q3 2026.
Under review
DNA fragmentation & IVF outcomes
Retrospective cohort study, ongoing.

Are you running clinical research with LensHooke or MiOXSYS? We'd love to collaborate.

Contact the scientific board →
Sources

Studies and product documentation.

Full publication list and white papers.

Contact our scientific board for the full reference list, clinical protocols and white papers.